Rising health care costs and life-cycle management in the pharmaceutical market.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 23785261.
- Also identified by DOI 10.1371/journal.pmed.1001461 and PMC identifier 3681333.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Aaron Kesselheim discusses Natalie Vernaz and colleagues' paper on the effects on health care costs of “evergreening” strategies pursued by drug manufacturers. <i>Please see later in the article for the Editors' Summary</i>
Medical subject headings
- Health Care Costs
- Nonprescription Drugs
- Patents as Topic